| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |